You have 8 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

cancer alternative therapies

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Cancer & Immune Cells in Ascites Fluid of Ovarian Cancer

Recruiting
  • Ovarian Cancer
    • Albuquerque, New Mexico
      University of New Mexico Cancer Center
    Oct 4, 2022

    Breast Cancer Trial in Toulouse (Treatment requiring adjuvant Hormonal Therapy (HT) with tamoxifen.)

    Recruiting
    • Breast Cancer
    • Treatment requiring adjuvant Hormonal Therapy (HT) with tamoxifen.
    • Toulouse, France
      Institut Universitaire du Cancer de Toulouse - Oncopole
    Mar 28, 2022

    Primary Hyperparathyroidism Trial in Boston (eplerenone, amiloride, Placebo)

    Completed
    • Primary Hyperparathyroidism
    • Boston, Massachusetts
      Brigham and Women's Hospital
    Nov 26, 2021

    Cancer, Fertility Issues, Fertility Preservation Trial (Blood samples for analysis, Sperm samples for analysis, Satisfaction

    Not yet recruiting
    • Cancer
    • +5 more
    • Blood samples for analysis
    • +3 more
    • (no location specified)
    May 22, 2023

    Quality of Life, Oral Mucositis, Dental Plaque Trial in Barcelona (The probiotic to be used in the intervention corresponds to

    Enrolling by invitation
    • Quality of Life
    • +5 more
    • The probiotic to be used in the intervention corresponds to PRODEFEN Plus manufactured by ITALFARMACO S.A. laboratory
    • Placebo
    • Barcelona, Spain
      University of Barcelona
    Nov 9, 2023

    Metastatic Castration-resistant Prostate Cancer (mCRPC), Prostatic Tumors Trial (MK-5684, Dexamethasone, Fludrocortisone

    Not yet recruiting
    • Metastatic Castration-resistant Prostate Cancer (mCRPC)
    • Prostatic Neoplasms
    • (no location specified)
    Nov 21, 2023

    Ovarian Cancer, Stage III Ovarian Cancer, Stage IV Ovarian Cancer Trial in Toronto (Niraparib)

    Not yet recruiting
    • Ovarian Cancer
    • +3 more
    • Toronto, Ontario, Canada
      Sunnybrook Research Institute
    Jul 18, 2023

    Prostate Cancer Metastatic Trial (MK-5684, Abiraterone acetate, Enzalutamide)

    Not yet recruiting
    • Prostate Cancer Metastatic
    • (no location specified)
    Nov 21, 2023

    Alternative Clinical Genetics Cancer Care Deliver Model

    Recruiting
    • Pancreas Cancer
    • +3 more
    • Genetic testing for hereditary predisposition
    • Philadelphia, Pennsylvania
      Penn Medicine - University of Pennsylvania
    Jan 30, 2023

    Nutritional Supplements & Complementary/Alternative Medicine by

    Active, not recruiting
    • Prostate Cancer
    • Breast Cancer
    • questionnaire administration
    • Columbus, Ohio
      Ohio State University Comprehensive Cancer Center
    Dec 9, 2022

    Learn About Novel Hormonal Therapies in People With Metastatic

    Not yet recruiting
    • Prostatic Neoplasms
    • Novel hormonal therapy
    • New York, New York
      Pfizer Inc
    Oct 2, 2023

    Prostate Cancer Trial in Heidelberg (Hypofractionated radiotherapy with photons, Hypofractionated radiotherapy with protons,

    Recruiting
    • Prostate Cancer
    • Hypofractionated radiotherapy with photons
    • +2 more
    • Heidelberg, Germany
      University Hospital Heidelberg
    Nov 2, 2022

    Cancer Trial in Philadelphia (Pre-Test Intervention, Standard of Care, Post-Test Intervention)

    Recruiting
    • Cancer
    • Pre-Test Intervention
    • +2 more
    • Philadelphia, Pennsylvania
      Abramson Cancer Center at University of Pennsylvania
    Jan 30, 2023

    NSCLC Trial in Busan (GDC-6036, Pembrolizumab)

    Recruiting
    • Non-Small Cell Lung Cancer
    • Busan, Korea, Republic of
      Pusan National University Hospital
    Apr 3, 2023

    Cancer-associated Fibroblast, MDSCs and Immune Cell Interplays

    Not yet recruiting
    • Lung Neoplasm
    • +2 more
    • Tumor samples
    • Bordeaux, France
      CHU de Bordeaux - Hôpital Saint-André, Service d'Oncologie Médic
    Aug 28, 2023

    Cancer Trial in Vejle (Open dialogue about CAM)

    Completed
    • Cancer
    • Open dialogue about CAM
    • Vejle, Denmark
      Vejle Hospital
    Jan 9, 2023

    Cancer Trial in Lexington (Therapeutic Intervention)

    Recruiting
    • Cancer
    • Therapeutic Intervention
    • Lexington, Kentucky
      Markey Cancer Center, University of Kentucky
    Nov 18, 2022

    Advanced Solid Tumor, Advanced Breast Cancer, Metastatic Breast Cancer Trial (BGB-43395, Fulvestrant, Letrozole)

    Not yet recruiting
    • Advanced Solid Tumor
    • +8 more
    • (no location specified)
    Nov 13, 2023

    Cancer Trial (Pre-Test Intervention, Standard of Care, Post-Test Intervention)

    Not yet recruiting
    • Cancer
    • Pre-Test Intervention
    • +2 more
    • (no location specified)
    Jun 16, 2022

    Colorectal Cancer, GIST Trial (DCC-3116, Ripretinib, Cetuximab)

    Not yet recruiting
    • Colorectal Cancer
    • GIST
    • (no location specified)
    Jul 14, 2023

    Specific Genetic Tests and Efficacy of Targeted Therapies in

    Recruiting
    • Non-small Cell Lung Cancer
      • Changsha, Hunan, China
        Hunan Cancer hospital
      Dec 26, 2022

      Skin Health and Quality of Life in Patients Receiving

      Not yet recruiting
      • Lung Cancer
      • +7 more
      • EQ-5D-5L questionnaire
      • +2 more
      • Roma, Italy
        Roberto Iacovelli
      May 17, 2023

      Ovarian Cancer, Fallopian Tube Cancer Trial in Houston (RIsk-Reducing Salpingectomy (RRS), Risk-Reducing Oophorectomy-RRO,

      Recruiting
      • Ovarian Cancer
      • Fallopian Tube Cancer
      • RIsk-Reducing Salpingectomy (RRS)
      • +2 more
      • Houston, Texas
        M D Anderson Cancer Center
      Dec 5, 2022

      Metastatic Prostate Cancer, Castration-Sensitive Prostate Cancer Trial in Shanghai (drug, procedure, radiation)

      Not yet recruiting
      • Metastatic Prostate Cancer
      • Castration-Sensitive Prostate Cancer
      • Shanghai, Shanghai, China
      • +1 more
      Feb 4, 2023

      Prostate Cancer Trial in Houston (Abiraterone Acetate, Prednisone, Sunitinib)

      Active, not recruiting
      • Prostate Cancer
      • Abiraterone Acetate
      • +3 more
      • Houston, Texas
        University of Texas MD Anderson Cancer Center
      Dec 6, 2022